Semarion

Cambridge, United Kingdom · Founded 2018 · Privately Held (backing)

Developer of a drug discovery and cell microcarrier platform designed to revolutionize adherent cell screening. Semarion is based in Cambridge, United Kingdom and was founded in 2018. Its last reported valuation was $39.6 million in Mar 2025. It has raised $7 million.

Last reported valuation
$39.6M
Oct 2026
Priced at
—
Total raised
$7.0M
Last round
—

Who backs Semarion?

10 investors
InvestorType
The FSE GroupVenture capital
Parkwalk AdvisorsVenture capital
Cambridge Enterprise VenturesVenture capital
Oxford Innovation FinanceOther
Cambridge Capital Group—
EMV Capital—
Found Capital—
Martlet Capital—
Start Codon—
University of Cambridge—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Semarion investors

10 investors are on record for Semarion, including The FSE Group, Parkwalk Advisors, Cambridge Enterprise Ventures and Oxford Innovation Finance.

Free account
More of Semarion with a free account
  • ·Watch Semarion: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Semarion. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View